Table 1.
Derivative | k−1 (min−1) | |||||
---|---|---|---|---|---|---|
A1 receptor | A2A receptor | A3 receptor | ||||
[3H]R-PIA (agonist) | [3H]DPCPX (antagonist) | [3H]CGS21680 (agonist) | [3H]ZM241385a (antagonist) | [125I]I-AB-MECA (agonist) | [3H]PSB-11 (antagonist) | |
Control | 0.012 ± 0.003 | 0.13 ± 0.02 | 0.066 ± 0.009 | 0.007 ± 0.002 | 0.059 ± 0.009 | 0.007 ± 0.001 |
+Amiloride (1 mM) | 0.012 ± 0.002 | 0.19 ± 0.02* | 0.087 ± 0.022 | 0.008 ± 0.002 | 0.058 ± 0.006 | 0.008 ± 0.002 |
+DMA (0.1 mM) | 0.013 ± 0.003 | 0.25 ± 0.04* | 0.084 ± 0.017 | NDb | 0.047 ± 0.009* | 0.009 ± 0.001* |
+HMA (0.1 mM) | 0.013 ± 0.003 | 0.22 ± 0.02* | ND | 0.080 ± 0 010* | 0.031 ± 0.006* | 0.016 ± 0 003* |
+MIBA(0.1mM) | ND | ND | ND | 0.040 ± 0005* | 0.035 ± 0.007* | 0.011 ±0002* |
Human A3 receptors were expressed in CHO cells, and the rat A3 receptor of RBL-2H3 cells was used. A1 and A2A receptors of rat brain (forebrain and striatum, respectively) were used. The k−1 values for [3H]PSB-11 were from an experiment performed at 4°; similar results from an experiment performed at 25° are shown in Fig. 4A. Results are expressed as mean ± SEM and are from at least three independent experiments performed in duplicate.
Data from Ref. [19].
ND = not determined.
P < 0.05, compared with the control.